The 9th AGBT-Precision Health meeting in Denver, Colorado, from September 4-6, is a platform that highlights groundbreaking technologies and their transformative impact on clinical diagnostics. Micronbrane Medical shares this mission. We are committed to revolutionizing the study, diagnosis, treatment, and surveillance of infectious diseases through our innovative and cost-effective metagenomic Next-Generation Sequencing (mNGS) technologies. Our vision is to drive precision medicine forward by enhancing our collective understanding of microorganisms, ultimately impacting human health and sustainability. Set up a time to talk.
Learn How to Optimize Short and Long Read Sequencing for Metagenomic Applications
Visit our poster at the AGBT-PH Conference 2024 to see how you can harness Oxford Nanopore Technologies (ONT) for whole genome sequencing (WGS), 16S+ITS and mNGS applications. We demonstrate effective host DNA depletion and microbial enrichment using the Devin™ Microbial DNA Enrichment Kit, enabling low-input samples to be sequenced with ONT’s Rapid PCR Barcoding Kit.
Discover how we reduced human reads from 97% to 14%, boosting microbial reads to 86%, paving the way for more sensitive and comprehensive metagenomic analyses.
mNGS is the Key to Precision Medicine in Infectious Disease
Metagenomic NGS is crucial for achieving precision medicine in infectious disease. It enables accurate detection of diverse pathogens, including resistant strains, supporting tailored treatments and improving patient outcomes. By bridging diagnostics and personalized care, mNGS transforms how we study, diagnose, and manage infections.
Our technologies enrich the understanding of microorganisms through innovative metagenomic collection devices, novel host depletion, mNGS-grade reagents, advanced metagenomic sequencing assays, plus rapid bioinformatic software.
© 2024 Micronbrane Medical